Litcius/Paper detail

Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells

Kalpana Tilekar, Neha Upadhyay, Markus Schweipert, Jessica D. Hess, Lucasantiago Henze Macias, Piotr Mrówka, Franz‐Josef Meyer‐Almes, Renato J. Aguilera, Cristina V. Iancu, Jun‐yong Choe, C. S. Ramaa

2020European Journal of Pharmaceutical Sciences36 citationsDOIOpen Access PDF

Topics & Concepts

GLUT1IC50ThiazolidinedioneGlucose transporterChemistryApoptosisGlucose Transporter Type 1Cancer cellDocking (animal)GLUT4Cell cycleBiochemistryCancer researchIn vitroBiologyCancerEndocrinologyInsulinType 2 diabetesMedicineDiabetes mellitusGeneticsNursingCancer, Hypoxia, and MetabolismBiochemical and Molecular ResearchPI3K/AKT/mTOR signaling in cancer
Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells | Litcius